Servier completes the acquisition of Edgewise Therapeutics' Muscular Dystrophy Business
Acquisition supports Servier's strategic ambition in rare neurology with sevasemten, a late-stage investigational treatment for Becker and Duchenne muscular dystrophies. The acquired asset and expert team strengthen Servier's commitment to innovate






![Image: [Official Launch] AGONG Durian Uses Blockchain to Authenticate Every Musang King](http://prnewswire.vietreader.com/thumb/208x280/2026-07/official-launch-agong-durian-uses-blockchain-to-authenticate-every-musang-king-1.jpg)

